Viewing nowPregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201205827 · Approved 2012.06.22 · Insurance code 640902360
Treatment of neuropathic pain; adjunctive treatment of partial-onset seizures; treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults and as an adjunctive therapy for partial seizures in epilepsy. It also helps alleviate symptoms of fibromyalgia. Due to these effects, it is widely used in pain management and the treatment of neurological disorders.
This medicine is administered orally as pregabalin, with the total daily dose divided into 2 doses, regardless of food. Because this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with Renal Impairment’.) 1. Neuropathic Pain 1) Peripheral Neuropathic Pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, the dose may subsequently be increased at 7-day intervals up to a maximum of 600 mg/day. 2) Central Neuropathic Pain Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation of Treatment’.) 2. Epilepsy Adults: This medicine may be administered at an initial dose of 150 mg/day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg/day after 1 week. If necessary, the dose may subsequently be increased at 7-day intervals up to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The starting dose is 75 mg twice daily (150 mg/day), and based on efficacy and tolerability, the dose may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at a dose of 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies were also conducted at a dose of 600 mg/day; however, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation of Treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. 5. Patients with Renal Impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys unchanged. Because the clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function Creatinine clearance (CLcr), (mL/min) Total daily dose of pregabalin a Method of administration Starting dose (mg/day) Maximum dose (mg/day) ≥60 / 150 / 600 / BID or TID ≥30 -<60 / 75 / 300 / BID or TID ≥15 -<30 / 25-50 / 150 / QD or BID <15 / 25 / 75 / QD Supplemental dose after hemodialysis / 25 / 100 / Single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the method of administration. b: A supplemental dose refers to an additional dose administered as a single dose. 6. Patients with Hepatic Impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Elderly Patients (65 years of age or older) Dose reduction may be necessary in elderly patients with impaired renal function.
Administration is not recommended for children under 12 years of age or adolescent patients aged 12 ~17 years because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts and behaviors, so if there are changes in mood or behavior during treatment, consult a healthcare professional immediately. Patients with hypersensitivity to this medication or with hereditary lactose intolerance should not use it. Patients with diabetes may experience effects on blood sugar control due to weight gain, so blood sugar medication adjustments may be necessary. If symptoms of angioedema (such as swelling of the face or around the mouth) occur, stop taking the medication immediately. Elderly patients should be cautious due to the risk of falls or injuries from dizziness or drowsiness until they become accustomed to this medication. Transient blurred vision or vision changes may occur, but symptoms can improve once the medication is discontinued. Suddenly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so discontinuation should be discussed with a healthcare professional. Patients with a history of substance abuse may have an increased risk of misuse, so special caution is needed when taking this medication. Patients with impaired kidney function may require dosage adjustments, and there have been cases where kidney function improved after discontinuation. Patients with heart diseases or congestive heart failure should use this medication cautiously. Taking with opioid analgesics may increase central nervous system depressant effects, so caution is advised. Patients with weakened respiratory function or elderly patients may be at risk for severe respiratory depression, so dosage adjustments may be necessary. It is not recommended to take this medication during early pregnancy due to the risk of fetal malformations. Women of childbearing potential should use effective contraception. Nursing mothers should avoid taking this medication as it is passed into breast milk. Caution is advised when driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as confusion, drowsiness, depression, or seizures may develop, and treatment such as hemodialysis may be necessary. This medication should be stored out of reach of children and should not be transferred to other containers. Rarely, serious skin reactions (such as Stevens-Johnson syndrome) may occur, so if any skin abnormalities develop, discontinue use immediately and inform a healthcare professional.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store this medication at room temperature, between 15 to 30 degrees Celsius, to maintain its effectiveness.
White hard capsule containing white powder
30 capsules/bottle, 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Ilhwa Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.